Literature DB >> 32245083

SARS-CoV-2 and Coronavirus Disease 2019: What We Know So Far.

Firas A Rabi1, Mazhar S Al Zoubi2, Ghena A Kasasbeh3, Dunia M Salameh3, Amjad D Al-Nasser4.   

Abstract

In December 2019, a cluster of fatal pneumonia cases presented in Wuhan, China. They were caused by a previously unknown coronavirus. All patients had been associated with the Wuhan Wholefood market, where seafood and live animals are sold. The virus spread rapidly and public health authorities in China initiated a containment effort. However, by that time, travelers had carried the virus to many countries, sparking memories of the previous coronavirus epidemics, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), and causing widespread media attention and panic. Based on clinical criteria and available serological and molecular information, the new disease was called coronavirus disease of 2019 (COVID-19), and the novel coronavirus was called SARS Coronavirus-2 (SARS-CoV-2), emphasizing its close relationship to the 2002 SARS virus (SARS-CoV). The scientific community raced to uncover the origin of the virus, understand the pathogenesis of the disease, develop treatment options, define the risk factors, and work on vaccine development. Here we present a summary of current knowledge regarding the novel coronavirus and the disease it causes.

Entities:  

Keywords:  COVID-19; Coronavirus; SARS; SARS-CoV-2; Wuhan; pandemic

Year:  2020        PMID: 32245083     DOI: 10.3390/pathogens9030231

Source DB:  PubMed          Journal:  Pathogens        ISSN: 2076-0817


  172 in total

Review 1.  COVID-19, cytokines, inflammation, and spices: How are they related?

Authors:  Ajaikumar B Kunnumakkara; Varsha Rana; Dey Parama; Kishore Banik; Sosmitha Girisa; Sahu Henamayee; Krishan Kumar Thakur; Uma Dutta; Prachi Garodia; Subash C Gupta; Bharat B Aggarwal
Journal:  Life Sci       Date:  2021-02-16       Impact factor: 5.037

2.  Computational Identification of Potential Anti-Inflammatory Natural Compounds Targeting the p38 Mitogen-Activated Protein Kinase (MAPK): Implications for COVID-19-Induced Cytokine Storm.

Authors:  Seth O Asiedu; Samuel K Kwofie; Emmanuel Broni; Michael D Wilson
Journal:  Biomolecules       Date:  2021-04-29

Review 3.  Scrutinizing Coronaviruses Using Publicly Available Bioinformatic Tools: The Viral Structural Proteins as a Case Study.

Authors:  Sonia Beeckmans; Edilbert Van Driessche
Journal:  Front Mol Biosci       Date:  2021-05-24

Review 4.  Flavonoids are promising safe therapy against COVID-19.

Authors:  Moza Mohamed Alzaabi; Rania Hamdy; Naglaa S Ashmawy; Alshaimaa M Hamoda; Fatemah Alkhayat; Neda Naser Khademi; Sara Mahmoud Abo Al Joud; Ali A El-Keblawy; Sameh S M Soliman
Journal:  Phytochem Rev       Date:  2021-05-22       Impact factor: 7.741

5.  Effect of the COVID-19 pandemic on health insurance coverage among trauma patients: a study of six level I trauma centers.

Authors:  Erica Sercy; Therese M Duane; Mark Lieser; Robert M Madayag; Gina Berg; Kaysie L Banton; David Hamilton; David Bar-Or
Journal:  Trauma Surg Acute Care Open       Date:  2021-04-02

6.  Prevention of Covid-19 affected patient using multi robot cooperation and Q-learning approach: a solution.

Authors:  Bandita Sahu; Pradipta Kumar Das; Manas Ranjan Kabat; Raghvendra Kumar
Journal:  Qual Quant       Date:  2021-05-06

Review 7.  Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management.

Authors:  Amjad M Husaini; Khan Nadiya Jan; Gowher A Wani
Journal:  Heliyon       Date:  2021-05-14

8.  Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) study: an observational cohort study of SARS-CoV-2 infection and vaccination in healthcare workers.

Authors:  Belinda M Jackson-Thompson; Emilie Goguet; Eric D Laing; Cara H Olsen; Simon Pollett; K Monique Hollis-Perry; Santina E Maiolatesi; Luca Illinik; Kathleen F Ramsey; Anatalio E Reyes; Yolanda Alcorta; Mimi A Wong; Julian Davies; Orlando Ortega; Edward Parmelee; Alyssa R Lindrose; Matthew Moser; Elizabeth Graydon; Andrew G Letizia; Christopher A Duplessis; Anuradha Ganesan; Kathleen P Pratt; Allison M Malloy; David W Scott; Stephen K Anderson; Andrew L Snow; Clifton L Dalgard; John H Powers; David Tribble; Timothy H Burgess; Christopher C Broder; Edward Mitre
Journal:  BMC Infect Dis       Date:  2021-06-09       Impact factor: 3.090

9.  Contribution of Syndecans to the Cellular Entry of SARS-CoV-2.

Authors:  Anett Hudák; Annamária Letoha; László Szilák; Tamás Letoha
Journal:  Int J Mol Sci       Date:  2021-05-19       Impact factor: 5.923

10.  Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review.

Authors:  Mayka Freire; Ariadna Andrade; Bernardo Sopeña; Maria Lopez-Rodriguez; Pablo Varela; Purificación Cacabelos; Helena Esteban; Arturo González-Quintela
Journal:  Autoimmun Rev       Date:  2021-06-10       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.